| Oct 3 |
Charles River Provides Translational Expertise at Neuroscience 2024
|
| Oct 2 |
Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease
|
| Oct 1 |
Bio-Rad upped by Citi to buy; Charles River, Hologic downgraded
|
| Sep 23 |
Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
|
| Sep 20 |
The Analyst Verdict: Charles River In The Eyes Of 10 Experts
|
| Sep 18 |
CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA
|
| Sep 17 |
Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
|
| Sep 9 |
CRL Stock May Benefit From New Neuroscience Research Collaboration
|
| Sep 6 |
Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report?
|
| Sep 6 |
Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)
|
